Challenges to heart failure medication prescribing post-hospitalization

Objectives To determine the prevalence of heart failure (HF) medication prescribing on discharge post-HF-related admission. Methods A retrospective audit was conducted for 216 HF admissions over a period of 6 months; medication data from electronic records were collected for analysis. Key findings The prevalence of HF medication prescribing on discharge was: 32.9% (95% confidence interval: 26.6–39.6) renin–angiotensin–aldosterone system inhibitors, 10.6% (6.9–15.6) angiotensin receptor-neprilysin inhibitors, 31.5% (25.4–38.1) HF-specific beta-blockers, 42.6% (35.9–49.5) aldosterone receptor antagonists, and 11.6% (7.6–16.6) sodium-glucose cotransporter-2 inhibitors. Conclusion HF medication prescribing remains relatively low despite the known benefits and recommendations listed in the guidelines.